Amundi Purchases 489,414 Shares of Agilon Health, Inc. $AGL

Key Points

• Amundi increased its stake in Agilon Health by 49.2%, acquiring an additional 489,414 shares, and now holds a total of 1,484,709 shares worth $5,939,000.
• Analysts have reduced their target prices for Agilon Health significantly, with Sanford C. Bernstein lowering it to $1.40, and Robert W. Baird dropping it to $1.00 while maintaining a "neutral" rating.
• Agilon Health's stock is currently trading at $1.13, down 2.2%, and analysts predict a negative earnings per share of -0.59 for the current fiscal year.

Amundi grew its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 49.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,484,709 shares of the company's stock after acquiring an additional 489,414 shares during the quarter. Amundi owned 0.36% of Agilon Health worth $5,939,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in AGL. Millennium Management LLC increased its stake in Agilon Health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Nuveen LLC bought a new stake in Agilon Health in the 1st quarter worth approximately $17,242,000. CenterBook Partners LP purchased a new position in shares of Agilon Health in the 1st quarter worth approximately $8,315,000. Invesco Ltd. boosted its holdings in shares of Agilon Health by 186.7% in the 1st quarter. Invesco Ltd. now owns 1,151,795 shares of the company's stock worth $4,987,000 after purchasing an additional 750,046 shares during the period. Finally, Two Sigma Advisers LP boosted its holdings in shares of Agilon Health by 4,393.5% in the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock worth $914,000 after purchasing an additional 470,100 shares during the period.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on AGL. Sanford C. Bernstein reiterated a "market perform" rating and issued a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Robert W. Baird dropped their target price on Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Jefferies Financial Group dropped their target price on Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a report on Friday, August 15th. Benchmark dropped their target price on Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a report on Wednesday, August 6th. Finally, Evercore ISI dropped their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a report on Wednesday, July 9th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $3.07.

Agilon Health Trading Down 2.2%

Shares of AGL stock opened at $1.13 on Thursday. Agilon Health, Inc. has a twelve month low of $0.71 and a twelve month high of $6.08. The stock has a market capitalization of $466.22 million, a price-to-earnings ratio of -1.46 and a beta of 0.11. The stock has a fifty day simple moving average of $1.60 and a two-hundred day simple moving average of $2.79.

Agilon Health (NYSE:AGL - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The firm had revenue of $1.39 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter in the prior year, the company posted ($0.07) earnings per share. Agilon Health's quarterly revenue was down 5.9% compared to the same quarter last year. Research analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.